Riverbridge Partners LLC Reduces Position in Option Care Health, Inc. $OPCH

Key Points

• Riverbridge Partners LLC reduced its stake in Option Care Health, Inc. by 12.6%, owning approximately 1,265,679 shares valued at $41 million after selling 183,176 shares.
• Institutional investors hold 98.05% of Option Care Health's stock, with notable investments from Two Sigma Investments LP and the Public Employees Retirement System of Ohio.
• Research analysts have a consensus rating of "Moderate Buy" for Option Care Health, with an average target price of $35.75 following recent earnings that exceeded expectations.

Riverbridge Partners LLC cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 12.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,265,679 shares of the company's stock after selling 183,176 shares during the period. Riverbridge Partners LLC owned approximately 0.77% of Option Care Health worth $41,109,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of OPCH. Two Sigma Investments LP boosted its position in shares of Option Care Health by 1,101.1% during the fourth quarter. Two Sigma Investments LP now owns 108,067 shares of the company's stock valued at $2,507,000 after buying an additional 99,070 shares during the last quarter. Squarepoint Ops LLC bought a new position in Option Care Health in the fourth quarter valued at about $280,000. Public Employees Retirement System of Ohio lifted its holdings in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares during the period. Mackenzie Financial Corp lifted its holdings in Option Care Health by 1.1% in the fourth quarter. Mackenzie Financial Corp now owns 49,579 shares of the company's stock valued at $1,150,000 after acquiring an additional 556 shares during the period. Finally, 111 Capital bought a new position in Option Care Health in the fourth quarter valued at about $315,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on OPCH shares. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Tuesday. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, JMP Securities lifted their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $35.75.

Insider Buying and Selling

In other news, Director Norman L. Wright purchased 3,411 shares of the company's stock in a transaction on Tuesday, September 9th. The shares were acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director directly owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 59,411 shares of company stock worth $1,627,576 in the last ninety days. 0.64% of the stock is owned by insiders.

Option Care Health Trading Down 0.7%

Shares of NASDAQ OPCH opened at $27.50 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The business has a fifty day simple moving average of $28.68 and a two-hundred day simple moving average of $31.12. The firm has a market cap of $4.46 billion, a PE ratio of 22.00, a price-to-earnings-growth ratio of 1.68 and a beta of 0.82. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.